WallStreetZenWallStreetZen

NASDAQ: PAHC
Phibro Animal Health Corp Earnings & Revenue

PAHC past earnings growth

How has PAHC's earnings growth performed historically?
Company
-53.52%
Industry
17.71%
Market
130.35%
PAHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PAHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PAHC's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PAHC past revenue growth

How has PAHC's revenue growth performed historically?
Company
2.19%
Industry
9.85%
Market
19.3%
PAHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PAHC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PAHC's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PAHC earnings and revenue history

Current Revenue
$999.6M
Current Earnings
$13.2M
Current Profit Margin
1.3%
PAHC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PAHC Return on Equity

Current Company
4.8%
Current Industry
13.2%
Current Market
28.2%
PAHC's Return on Equity (4.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PAHC announces earnings.

PAHC Return on Assets

Current Company
1.4%
Current Industry
2.9%
PAHC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PAHC Return on Capital Employed

Current Company
5.6%
Current Industry
4.8%
PAHC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PAHC vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PAHC$999.56M$79.80M$13.16M+3.64%-27.78%
PETQ$1.12B$86.37M$7.34M+14.79%+12.30%
HROW$138.68M$4.49M-$31.33M+25.36%N/A
EOLS$219.70M-$38.05M-$60.00M+48.30%N/A
SIGA$157.02M$102.76M$79.26M-20.22%-27.31%

Phibro Animal Health Earnings & Revenue FAQ

What were PAHC's earnings last quarter?

On Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q1 2024 earnings per share (EPS) of $0.21, up 16% year over year. Total Phibro Animal Health earnings for the quarter were $8.41 million. In the same quarter last year, Phibro Animal Health's earnings per share (EPS) was $0.25.

If you're new to stock investing, here's how to buy Phibro Animal Health stock.

What was PAHC's earnings growth in the past year?

As of Q2 2024, Phibro Animal Health's earnings has grown -53.52% year over year. This is 71.23 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 17.71%. Phibro Animal Health's earnings in the past year totalled $13.16 million.

What was PAHC's revenue last quarter?

On Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q1 2024 revenue of $263.22 million up 7.14% year over year. In the same quarter last year, Phibro Animal Health's revenue was $245.67 million.

What was PAHC's revenue growth in the past year?

As of Q2 2024, Phibro Animal Health's revenue has grown 2.19% year over year. This is 7.65 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 9.85%. Phibro Animal Health's revenue in the past year totalled $999.56 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.